• Study on the Effectiveness and Safety of Pembrolizumab, Quavonlimab, and Lenvatinib for Patients with Advanced Small Cell Lung Cancer Needing Second-Line Treatment

    Not recruiting

    1 1 1 1
    Austria Hungary Italy Poland Spain
  • Study comparing giredestrant plus palbociclib versus letrozole plus palbociclib in patients with estrogen receptor-positive, HER2-negative advanced or metastatic breast cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    Austria Belgium Denmark France Germany Greece +5
  • Study on ALXN1850 for Adolescents and Adults with Hypophosphatasia Not Previously Treated with Asfotase Alfa

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium France Germany Italy Poland +2
  • Study on the Effectiveness and Safety of Cryotherapy and Tirbanibulin for Actinic Keratosis in Organ Transplant Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain
  • Study on Chemotherapy with Paclitaxel, Cisplatin, and Carboplatin for Patients with Resected Stage I or IIA Non-Squamous Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    France Germany
  • Study on Insulin Lispro and Insulin Human for Managing Blood Sugar After Meals in Type 1 Diabetes Patients with Different Gastric Emptying Rates

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Germany
  • Study on the Effectiveness and Safety of Ravulizumab for Children and Adolescents with Neuromyelitis Optica Spectrum Disorder (NMOSD)

    Not recruiting

    4 1 1 1
    Investigated Drugs:
    France Italy Spain
  • Study on the Effectiveness and Safety of Rosnilimab for Patients with Moderate to Severe Ulcerative Colitis

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Bulgaria Croatia France Germany Italy +4
  • Study of Niraparib, Abiraterone Acetate, and Prednisone for Patients with Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer

    Not recruiting

    3 1 1
    Belgium Bulgaria Czechia Denmark France Germany +7
  • Study on the Effects and Safety of Namilumab for Patients with Chronic Lung Sarcoidosis

    Not recruiting

    2 1
    Investigated Drugs:
    Belgium France Germany The Netherlands

powered by